Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 196 | 3 | LUNG CANCER//NON SMALL CELL LUNG CANCER//THORAC SURG | 53631 |
| 440 | 2 | GEFITINIB//EGFR//EPIDERMAL GROWTH FACTOR RECEPTOR | 16519 |
| 9526 | 1 | APATINIB//HER2//GASTRIC CANCER | 1178 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | APATINIB | authKW | 499961 | 2% | 64% | 29 |
| 2 | HER2 | authKW | 353507 | 16% | 7% | 192 |
| 3 | GASTRIC CANCER | authKW | 349388 | 37% | 3% | 440 |
| 4 | TRASTUZUMAB | authKW | 219800 | 11% | 6% | 128 |
| 5 | HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 | authKW | 150652 | 3% | 14% | 40 |
| 6 | GASTROESOPHAGEAL CANCER | authKW | 86844 | 1% | 19% | 17 |
| 7 | RAMUCIRUMAB | authKW | 80979 | 2% | 17% | 18 |
| 8 | HER 2 | authKW | 72133 | 4% | 6% | 43 |
| 9 | UNIV CANC LEIPZIG | address | 62414 | 1% | 33% | 7 |
| 10 | GASTRO OESOPHAGEAL JUNCTION CANCER | authKW | 60193 | 0% | 75% | 3 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 16845 | 61% | 0% | 724 |
| 2 | Pathology | 2872 | 14% | 0% | 167 |
| 3 | Gastroenterology & Hepatology | 2126 | 13% | 0% | 155 |
| 4 | Cell Biology | 115 | 7% | 0% | 84 |
| 5 | Surgery | 111 | 7% | 0% | 88 |
| 6 | Medicine, Research & Experimental | 100 | 5% | 0% | 55 |
| 7 | Medical Laboratory Technology | 90 | 2% | 0% | 20 |
| 8 | Pharmacology & Pharmacy | 33 | 6% | 0% | 69 |
| 9 | Biotechnology & Applied Microbiology | 28 | 4% | 0% | 43 |
| 10 | Anatomy & Morphology | 28 | 1% | 0% | 10 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | UNIV CANC LEIPZIG | 62414 | 1% | 33% | 7 |
| 2 | GEORGIUS AGR STIFTUNG RUHR | 60193 | 0% | 75% | 3 |
| 3 | FALCK | 53506 | 0% | 100% | 2 |
| 4 | UNIV KREBSZENTRUM UCCL | 48153 | 0% | 60% | 3 |
| 5 | UNIT GEN MINIMALLY INVAS SURG | 37150 | 0% | 28% | 5 |
| 6 | CHARITE TUMORMED CC14 | 35669 | 0% | 67% | 2 |
| 7 | SURGGASTR CANC | 35669 | 0% | 67% | 2 |
| 8 | CANC GENOM BIOCHEM | 35665 | 0% | 33% | 4 |
| 9 | HOSP UNIV MADRID SANCHINARRO | 30093 | 0% | 38% | 3 |
| 10 | NEW EXPT THER EUT BRANCH | 27507 | 1% | 17% | 6 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | GASTRIC CANCER | 40574 | 3% | 4% | 34 |
| 2 | ONCOTARGETS AND THERAPY | 3890 | 2% | 1% | 18 |
| 3 | WORLD JOURNAL OF GASTROENTEROLOGY | 2735 | 4% | 0% | 42 |
| 4 | ONCOTARGET | 2701 | 3% | 0% | 41 |
| 5 | DISEASES OF THE ESOPHAGUS | 2378 | 1% | 1% | 13 |
| 6 | BMC CANCER | 2298 | 2% | 0% | 26 |
| 7 | INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 1806 | 1% | 1% | 8 |
| 8 | ANNALS OF ONCOLOGY | 1782 | 2% | 0% | 24 |
| 9 | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | 1715 | 1% | 1% | 10 |
| 10 | CURRENT TREATMENT OPTIONS IN ONCOLOGY | 1594 | 0% | 1% | 5 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | APATINIB | 499961 | 2% | 64% | 29 | Search APATINIB | Search APATINIB |
| 2 | HER2 | 353507 | 16% | 7% | 192 | Search HER2 | Search HER2 |
| 3 | GASTRIC CANCER | 349388 | 37% | 3% | 440 | Search GASTRIC+CANCER | Search GASTRIC+CANCER |
| 4 | TRASTUZUMAB | 219800 | 11% | 6% | 128 | Search TRASTUZUMAB | Search TRASTUZUMAB |
| 5 | HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 | 150652 | 3% | 14% | 40 | Search HUMAN+EPIDERMAL+GROWTH+FACTOR+RECEPTOR+2 | Search HUMAN+EPIDERMAL+GROWTH+FACTOR+RECEPTOR+2 |
| 6 | GASTROESOPHAGEAL CANCER | 86844 | 1% | 19% | 17 | Search GASTROESOPHAGEAL+CANCER | Search GASTROESOPHAGEAL+CANCER |
| 7 | RAMUCIRUMAB | 80979 | 2% | 17% | 18 | Search RAMUCIRUMAB | Search RAMUCIRUMAB |
| 8 | HER 2 | 72133 | 4% | 6% | 43 | Search HER+2 | Search HER+2 |
| 9 | GASTRO OESOPHAGEAL JUNCTION CANCER | 60193 | 0% | 75% | 3 | Search GASTRO+OESOPHAGEAL+JUNCTION+CANCER | Search GASTRO+OESOPHAGEAL+JUNCTION+CANCER |
| 10 | HER2 TESTING | 60181 | 1% | 25% | 9 | Search HER2+TESTING | Search HER2+TESTING |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |
| rank | cluster_id2 | link |
|---|---|---|
| 1 | 4781 | S 1//ADVANCED GASTRIC CANCER//GASTRIC CANCER |
| 2 | 17186 | DNA MULTIPLOIDY//CDNA MICROARRAY BASED CGH//GASTRIC CANCER |
| 3 | 1360 | HER 2 NEU//C ERBB 2//HER2 |
| 4 | 3197 | TRASTUZUMAB//LAPATINIB//PERTUZUMAB |
| 5 | 21232 | ECRG2//ECRG1//ESOPHAGEAL SQUAMOUS CELL CARCINOMA |
| 6 | 28064 | TOP2A//TOPOISOMERASE II ALPHA//TOPO2A |
| 7 | 29333 | METASTASIS BIOPSY//RECEPTOR CONVERSION//DISCORDANCE |
| 8 | 27440 | CODON 655//HER2 POLYMORPHISM//ILE655VAL |
| 9 | 6250 | NIMOTUZUMAB//CETUXIMAB//EGFR |
| 10 | 1982 | PANITUMUMAB//CETUXIMAB//KRAS |